News on DuPont UK Limited from BioPortfolio.com http://www.BioPortfolio.com Consolidated DuPont UK Limited news from BioPortfolio.com Wed, 10 Feb 2010 07:10:40 GMT en Tomorrow's Company Eventshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035863&HITNO=0&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035863&THISHREF=http://c.moreover.com/click/here.pl%3fz2536403661%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035863&HITNO=0&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035863&THISHREF=http://c.moreover.com/click/here.pl%3fz2536403661%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMurray Income Trust: BRIEF-Biogen Idec comments on outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038494&HITNO=1&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038494&THISHREF=http://c.moreover.com/click/here.pl%3fz2537632242%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038494&HITNO=1&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038494&THISHREF=http://c.moreover.com/click/here.pl%3fz2537632242%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: Angel Biotechnology announces contract with Progenteqhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038221&HITNO=2&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038221&THISHREF=http://c.moreover.com/click/here.pl%3fz2537534835%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038221&HITNO=2&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038221&THISHREF=http://c.moreover.com/click/here.pl%3fz2537534835%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: BRIEF-Biogen Idec CEO says search for successor 'under way,' will not comment furtherhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035622&HITNO=3&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035622&THISHREF=http://c.moreover.com/click/here.pl%3fz2536300429%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035622&HITNO=3&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035622&THISHREF=http://c.moreover.com/click/here.pl%3fz2536300429%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: BEFORE THE BELL-Monsanto rises after upgradehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035138&HITNO=4&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035138&THISHREF=http://c.moreover.com/click/here.pl%3fz2536130234%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035138&HITNO=4&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035138&THISHREF=http://c.moreover.com/click/here.pl%3fz2536130234%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: BRIEF-Aastrom Biosciences announces reverse stock splithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035135&HITNO=5&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035135&THISHREF=http://c.moreover.com/click/here.pl%3fz2536128234%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035135&HITNO=5&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035135&THISHREF=http://c.moreover.com/click/here.pl%3fz2536128234%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: UK says Novartis, Bristol cancer drugs too costlyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032559&HITNO=6&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032559&THISHREF=http://c.moreover.com/click/here.pl%3fz2534704879%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032559&HITNO=6&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032559&THISHREF=http://c.moreover.com/click/here.pl%3fz2534704879%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters UK: UK says Novartis, Bristol cancer drugs too costlyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032137&HITNO=7&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032137&THISHREF=http://c.moreover.com/click/here.pl%3fz2534518266%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032137&HITNO=7&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032137&THISHREF=http://c.moreover.com/click/here.pl%3fz2534518266%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSharenet: Alliance Pharma PLC : Acquisition and Placinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027811&HITNO=8&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027811&THISHREF=http://c.moreover.com/click/here.pl%3fz2532368556%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027811&HITNO=8&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027811&THISHREF=http://c.moreover.com/click/here.pl%3fz2532368556%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInvestegate: Randgold Resources Final Dividend for 2009 - Election for Sterling Dividendhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027708&HITNO=9&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027708&THISHREF=http://c.moreover.com/click/here.pl%3fz2532304011%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027708&HITNO=9&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027708&THISHREF=http://c.moreover.com/click/here.pl%3fz2532304011%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: BRIEF-US FDA postpones cancer drugs meeting due to weatherhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031972&HITNO=10&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031972&THISHREF=http://c.moreover.com/click/here.pl%3fz2534451935%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031972&HITNO=10&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031972&THISHREF=http://c.moreover.com/click/here.pl%3fz2534451935%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: BRIEF-YM BioSciences Q2 resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031678&HITNO=11&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031678&THISHREF=http://c.moreover.com/click/here.pl%3fz2534320520%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031678&HITNO=11&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031678&THISHREF=http://c.moreover.com/click/here.pl%3fz2534320520%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: BRIEF-Anthera Pharma says FDA agrees on varespladib trial designhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028788&HITNO=12&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028788&THISHREF=http://c.moreover.com/click/here.pl%3fz2532858468%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028788&HITNO=12&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028788&THISHREF=http://c.moreover.com/click/here.pl%3fz2532858468%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: BRIEF-Novavax terminates negotiations with Rovi Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027713&HITNO=13&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027713&THISHREF=http://c.moreover.com/click/here.pl%3fz2532308226%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027713&HITNO=13&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027713&THISHREF=http://c.moreover.com/click/here.pl%3fz2532308226%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: Relenza royalty for December 2009 quarterhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026975&HITNO=14&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026975&THISHREF=http://c.moreover.com/click/here.pl%3fz2531612992%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026975&HITNO=14&MSIZE=293&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DuPont%20UK%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026975&THISHREF=http://c.moreover.com/click/here.pl%3fz2531612992%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: